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Received March 19, 2012; accepted August 25, 2012AbstractBackground: There have been few studies focusing on the incidence and risk factors for elderly patients undergoing computed tomography (CT)
scans with intravascular contrast medium, who develop contrast-induced nephropathy (CIN) in the emergency department (ED). Our objective
was to investigate the incidence of and risk factors for, CIN in elderly patients seen in the ED, who receive intravenous contrast media for CT
examination.
Methods: Patients 65 years of age who received contrast-enhanced CT were eligible for inclusion in this retrospective analysis. CIN was
defined as an increase in serum creatinine (sCr) 0.5 mg/dL 48 to 72 hours after intravenous contrast administration. Multiple logistic regression
analysis for risk factors for CIN and Chi-square test were performed for trend analysis for CIN incidence and mortality of different risk scores.
Results: A total of 594 patients, with a mean age of 79.8  6.8 years were included. The overall incidence of CIN was 8.6%. In multivariate
analyses, CIN was associated with diabetes mellitus [adjusted odds ratio (OR) ¼ 1.93; 95% confidence interval (CI) ¼ 1.04e3.62], precontrast
sCr >1.5 mg/dL (OR ¼ 2.72; 95% CI ¼ 1.44e5.13), and acute hypotension (OR ¼ 3.56; 95% CI ¼ 1.29e9.84). CIN and mortality increased
with increasing risk score ( p < 0.001 and p ¼ 0.001, respectively). The all-cause in-hospital mortality rate was 13.1%, and the mortality rates for
patients with and without CIN ( p < 0.001) were 47.1% and 9.9%, respectively.
Conclusion: Our investigation confirmed diabetes mellitus, precontrast sCr >1.5 mg/dL and acute hypotension as risk factors for CIN, and also
developed a simple risk score for elderly patients seen in the ED.
Copyright  2013 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Contrast-enhanced computed tomography (CT) provides
valuable information for prompt diagnosis and treatment
guidance of patients with acute illnesses seen in the* Corresponding author. Dr. David Hung-Tsang Yen, Department of Emer-
gency Medicine, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai
Road, Taipei 112, Taiwan, ROC.
E-mail address: hjyen@vghtpe.gov.tw (D.H.-T. Yen).
1726-4901/$ - see front matter Copyright  2013 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2013.01.007emergency department (ED). Contrast-induced nephropathy
(CIN) has been increasingly recognized in the past decade, and
is usually reported in patients undergoing primary angioplasty
or interventional coronary procedures.1e5 Several risk factors
for CIN have been reported, including chronic kidney disease,
diabetes mellitus, heart failure, advanced age, hypertension,
anemia, hypotension, use of an intra-aortic balloon pump, and
left ventricular ejection fraction <40%, as well as the type and
dose of the contrast medium used.2,3,6e8hinese Medical Association. All rights reserved.
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CIN involved patients undergoing coronary angiography or
interventional procedures with a higher dose of contrast me-
dium than patients who received CT scans with intravascular
contrast medium in the ED. The clinical characteristics of
acutely ill patients seen in the ED may differ significantly
from those of patients undergoing coronary angiography, in
that they may have more unidentified risk factors and unstable
clinical conditions. In addition, with the increase in age of the
world population, more elderly patients are being seen in the
ED and require CT with contrast.
To our knowledge, there has been little study focusing on
the risk factors for elderly patients undergoing CT scans with
intravascular contrast medium who develop CIN in the ED
setting. Thus, the aim of this study was first, to investigate the
incidence of, risk factors for, and prognostic implications of
CIN in elderly patients receiving intravenous contrast medium
for either chest or abdomen CT in the ED. Second, we
attempted to establish a simple risk score for the prediction of
CIN and mortality of elderly patients who receive contrast-
enhanced CT imaging in the ED.
2. Methods2.1. Study design and settingWe retrospectively reviewed the records of all consecutive
patients seen at our ED in a medical teaching center in northern
Taiwan, from January 1 to June 30, 2007. The average annual ED
patient census was 80,146 during the period of 2005 to 2007.
Patients 65 years of age, and who received chest or abdomen
contrast-enhancedCT,were eligible for inclusion in the analysis.
A 40-slice CT scanner (Philips Brilliance 40CTScanner, Philips
Medical Systems (Cleveland), Inc., Ohio, USA) is used in the
ED, which is available 24 hours a day, 7 days a week. Patients
receiving long-term hemodialysis, who received another dose of
contrast medium within 72 hours, and whose medical records
were incomplete, were excluded from analysis. This observa-
tional study was approved by the Institutional Ethics Review
Board of our hospital, and due to the retrospective nature of the
study, the requirement of informed patient consent was waived.2.2. Data collectionData collected from patient medical records and the hospital
electronic database included patient demographic characteris-
tics, precontrast serum creatinine level (sCr) and postcontrast
sCr 48e72 hours after CT examination, hemoglobin level,
medical history, administration of inotropic agents in the ED,
contrast dose and type, tentative diagnosis in the ED and final
diagnosis at discharge, temporary or permanent dialysis after
CT examination, and in-hospital mortality.2.3. DefinitionsElderly was defined as 65 years of age. Anemia was
defined using established the World Health Organizationcriterion: baseline hematocrit value <39% for men, and <36%
for women.9 Baseline sCr was defined as stable sCr within
1 year prior to receiving the index CT examination. Precon-
trast sCr was that obtained before the index CT examination
during the same ED visit, and postcontrast sCr was the value
obtained 48 to 72 hours after the index CT examination. CIN
was defined as an increase in sCr 0.5 mg/dL 48 to 72 hours
after intravascular contrast administration.1,10,11 Acute hypo-
tension was defined as health status requiring the use of va-
sopressors, in addition to adequate fluid supplementation. To
estimate the glomerular filtration rate (eGFR), we used the
simplified Modification of Diet in Renal Disease (MDRD)
formula12: eGFR (mL/min/1.73 m2) ¼ 186  (creatinine, mg/
dL)1.154  (age, years)0.203 (0.742 in women).2.4. Statistical analysisData are presented as mean  standard deviation (SD) for
continuous variables and as number (%) for categorical vari-
ables. For continuous variables, the two groups were
compared with the independent two-sample t test; however,
the Wilcoxon rank sum test was used when data were highly
skewed. Univariate analyses were performed using the Chi-
square test or the Fisher’s exact test, for the comparison of
categorical variables as appropriate. Multivariate logistic
regression was conducted to identify significant independent
clinical predictors of CIN and to estimate odds ratios (ORs).
Risk factors that were statistically significant in the multivar-
iate analyses were selected for inclusion in the prediction
model. Chi-square for trend test with Kendall’s rank correla-
tion tau-b was used for analysis of the relationship between the
CIN incidence and mortality rates in different age groups, risk
scores, and risk grades. All analyses were two-tailed, and a p
value < 0.05 was considered statistically significant. All an-
alyses were performed using SPSS version 16.0 statistical
software (SPSS Inc, Chicago, IL, USA).3. Results
A total of 35,404 nontrauma patients were screened during
the 6-month study period, and there were 14,398 patients 65
years of age (40.7% of the total patients). Among all elderly
patients, 2245 patients (15.6%) received CT imaging; of these,
803 patients received chest or abdomen CT examinations with
intravenous contrast medium. After excluding patients who
met the exclusion criteria, a total of 594 patients were eligible
for inclusion in the analysis (Fig. 1). The clinical data of the
594 study patients, with a mean age of 79.8  6.8 years, are
shown in Table 1. The overall incidence of CIN was 8.6%. The
incidence of temporary hemodialysis was 0.5% (3 of the 594
patients), and no patient required permanent hemodialysis.
The all-cause in-hospital mortality rate was 13.1%, and the
incidence of CIN and mortality in patients grouped by age
(65e74 years, 75e84 years, and >84 years) are shown in
Fig. 2. There was no statistically significant difference in CIN
incidence between these age groups; however, an increasing
Nontrauma emergency patients 
n = 35,404 
Age < 65 years 
n = 21,006 (59.3%) 
Age ≥ 65 years 
n = 14,398 (40.7%)
Did not receive CT scanning 
n = 12,153 (84.4%) 
Received CT scanning 
n = 2,245 (15.6%) 
Not chest or abdomen CT 
n = 1,233 (54.9%) 
Chest or abdomen CT 
n = 1,012 (45.1%) 
Did not receive contrast media 
n = 209 (20.7%) 
Received contrast media 
n = 803 (79.3%) 
Data not complete 
n = 209 (26.0%) 
Date complete 
n = 594 (74.0%)
Fig. 1. Flow diagram of patient enrollment.
Table 1
Clinical characteristics of 594 study patients.
Age (y) 79.8  6.8
Age 85 y 135 (22.7)
Female 155 (26.1)
Diabetes mellitus 137 (23.1)
Hypertension 330 (55.6)
Heart failure 64 (10.8)
Hemoglobin (g/dL) 12.1  2.2
Anemia 359 (60.4)
Baseline serum creatinine (mg/dL) 0.96  0.37
1.5 570 (95.9)
1.6e2.0 20 (3.3)
>2.0 5 (0.8)
Precontrast serum creatinine (mg/dL) 1.26  0.61
1.5 481 (81.0)
1.6e2.0 88 (14.8)
>2.0 25 (4.2)
Precontrast eGFR (mL/min/1.73 m2) 63.5  24.5
90 58 (9.8)
60e89 246 (41.4)
30e59 265 (44.6)
15e29 15 (2.5)
<15 10 (1.7)
Abdominal CT 404 (68.0)
Contrast media volume (mL) 98.6  6.4
Ionic contrast media 150 (25.3)
Acute hypotensiona 22 (3.7)
Temporary hemodialysis 3 (0.5)
Permanent hemodialysis 0 (0)
In-hospital mortality 78 (13.1)
CIN ¼ contrast-induced nephropathy.
CIN was defined as an increase of serum creatinine of 0.5 mg/dL 48 to 72
hours after contrast-enhanced CT imaging.
Data are presented as mean  standard deviation or number (%).
a Acute hypotension defined as the requirement of use of vasopressors in
addition to adequate fluid supplementation.
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Fig. 2. The incidence of contrast-induced nephropathy (CIN) and mortality in
patients grouped by age (65e74 years, 75e84 years, and > 84 years). Data are
presented as percentage  standard error. For CIN incidence, p ¼ 0.618 and
for mortality, p ¼ 0.073, by Chi-square for trend analysis.
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groups was noted.
Univariate analyses of clinical characteristics associated
with CIN are shown in Table 2. There were six variables:
hypertension, diabetes mellitus, precontrast sCr >1.5 mg/dL,
precontrast eGFR <60 mL/min/1.73 m2, baseline sCr
>1.5 mg/dL, and acute hypotension, which were significantly
associated with the development of CIN after contrast-
enhanced CT imaging. Multivariate logistic regression ana-
lyses of these six variables determined to be significant in
univariate analyses, demonstrated that diabetes mellitus, pre-
contrast sCr >1.5 mg/dL, and acute hypotension remained
statistically significant clinical factors of CIN. The adjusted
ORs of diabetes mellitus, precontrast sCr >1.5 mg/dL, and
acute hypotension for the development of CIN are 1.93, 2.72,
and 3.56, respectively (Table 3).
To investigate whether these significant clinical factors can
be used for risk stratification of CIN and in-hospital mortality,
we set the integer score as “1” for diabetes mellitus, “2” for
precontrast sCr >1.5 mg/dL, and “2” for acute hypotension,based on their individual adjusted ORs. The increases in risk
scores were significantly correlated with the increases in CIN
incidence and in-hospital mortality by Chi-square for trend
analysis ( p < 0.001 and p ¼ 0.001, respectively). All patients
Table 2
Univariate analysis of the association of patient clinical characteristics and
contrast-induced nephropathy (CIN) after contrast-enhanced computed to-
mography (CT) imaging.
Variable Number
(%)
Incidence
of CIN (%)
OR 95% CI p
All patients 594 (100) 8.6 e e e
Precontrast sCr >1.5 113 (19.0) 18.6 3.43 1.88e6.26 <0.001
Acute hypotensiona 22 (3.7) 31.8 5.60 2.17e14.5 0.001
Baseline sCr >1.5 24 (4.1) 23.8 4.41 1.52e12.8 0.014
Diabetes mellitus 137 (23.1) 14.6 2.35 1.29e4.27 0.004
Hypertension 330 (55.6) 10.9 2.03 1.09e3.80 0.024
Precontrast eGFR <60 290 (48.8) 11.0 1.86 1.03e3.36 0.037
Female 155 (26.1) 11.6 1.62 0.88e2.96 NS
Anemia 359 (60.4) 9.5 1.34 0.73e2.46 NS
Age 85 y 135 (22.7) 7.4 0.82 0.40e1.68 NS
Ionic contrast media 150 (25.3) 6.2 0.63 0.30e1.32 NS
CIN ¼ contrast-induced nephropathy; CT ¼ computed tomography;
sCr ¼ serum creatinine (mg/dL); OR ¼ odds ratio; CI ¼ confidence interval;
NS ¼ nonsignificant.
CIN was defined as an increase of serum creatinine of 0.5 mg/dL 48 to 72
hours after contrast-enhanced CT imaging.
a Acute hypotension defined as the requirement of vasopressors in addition
to adequate fluid supplementation.
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Fig. 3. The incidence of contrast-induced nephropathy (CIN) and mortality in
patients grouped by different risk grades. Patients with risk scores of 0, 1e2,
and 3e5 were categorized into low, medium and high risk grades, respectively.
Data are presented as percentage  standard error. For CIN incidence,
p < 0.001 and for mortality, p < 0.001, by Chi-square for trend analysis for
different risk grade groups.
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score of 0, n ¼ 372), moderate risk (risk score of 1e2,
n ¼ 177), and high risk (risk score of 3e5, n ¼ 45). An
increased risk grade was correlated with an increased CIN
incidence and mortality by Chi-square for trend analysis
( p < 0.001 and p ¼ 0.001, respectively, Fig. 3). In patients
categorized as high risk, the incidences of CIN and in-hospital
mortality were 28.9% and 37.8%, respectively.
To evaluate the possible association of disease with CIN
incidence and mortality, we categorized all patients into eight
disease groups: cardiovascular, pulmonary, hepatobiliary,
gastrointestinal, pancreatic, genitourinary, sepsis of unknown
origin, and others. The incidences of CIN and mortality in
these disease groups are shown in Table 4. There was no
overall statistical significance between the eight disease
groups and incidence of CIN. Only patients with sepsis of an
unknown origin were found to have a higher mortality rate
than those without sepsis ( p < 0.001).
Of the total 594 patients in our study, 78 patients (13.1%)
died during hospitalization, and the in-hospital mortality rateTable 3
Multivariate analysis of predictors of contrast-induced nephropathy (CIN)
after contrast-enhanced computed tomography (CT) imaging.
Variable Integer
score
Model
coefficient
Adjusted
OR
95% CI p
Diabetes mellitus 1 0.660 1.93 1.04e3.62 0.039
Precontrast sCr >1.5 2 0.999 2.72 1.44e5.13 0.002
Acute hypotensiona 2 1.270 3.56 1.29e9.84 0.014
CIN ¼ contrast-induced nephropathy; CT ¼ computed tomography;
sCr ¼ serum creatinine (mg/dL); OR ¼ odd ratio; CI ¼ confidence interval.
CIN was defined as an increase of serum creatinine of 0.5 mg/dL 48 to 72
hours after contrast-enhanced CT imaging.
a Acute hypotension defined as the requirement of vasopressors in addition
to adequate fluid supplementation.was 47.1% and 9.9%, respectively, in patients with and
without CIN ( p < 0.001). Thus, CIN was associated with a
significantly increased risk for death from all causes.4. Discussion
Studies have shown that CIN will occur in 2e25% of pa-
tients undergoing coronary intervention and in 0.5e5.5% of
patients after CT examination.7,13e18 The wide range of re-
ported incidence of CIN depends on the study design and
definition used to identify those with kidney injury. In this
study, we adopted the most common definition of CIN, which
is based on an increase of sCr 48 to 72 hours after the pro-
cedure. This method typically can identify most cases of CIN.
However, it is also possible that this method may omit some
CIN cases, as the peak sCr may occur in 15% of patients as
long as 7 days after contrast-enhanced CT is administered.19
Our observational study indicated that the incidence of CIN
was 8.6% in patients with a mean age of 80 years who were
seen in the ED and who received intravenous contrast medium
for CT examinations. Age was found to be a major predictive
factor of CIN in previous studies that primarily focused on
patients undergoing coronary interventions and were relatively
stable to tolerate the procedures.1,2,6,7,10,11 Thus, our study
focused on elderly patients seen in the ED who usually have
more complicated underlying diseases and are less stable, and
have medical conditions requiring urgent management.
Although one of the results of this study showed that the
incidence of CIN peaks in the elderly between the ages of 75
and 84 years (10.1%), there is no statistical significance in the
incidence of CIN correlated with the increase of age in elderly
patients. However, most previous reports suggest that this
subset of the general population still has a relatively higher
incidence of CIN than the younger population, and merits
Table 4
Incidence of CIN by disease categories.
Disease categories Number (%) Incidence of CIN (95% CI) Mortality (95% CI)
All 594 (100.0) 8.6 (6.34e10.85) 13.1 (10.37e15.82)
Sepsis, unknown origin 19 (3.2) 21.1 (2.77e39.43) 47.4 (24.96e69.84)*
Cardiovascular system 53 (8.9) 15.1 (5.46e24.73) 13.2 (4.09e22.31)
Pancreas 20 (3.4) 10.0 (0e23.15) 20.0 (2.48e37.52)
Gastrointestinal system 147 (24.7) 8.8 (4.21e13.38) 6.8 (2.72e10.88)
Pulmonary system 176 (29.6) 8.5 (4.38e12.62) 19.3 (13.46e25.14)
Hepatobiliary system 127 (21.4) 5.5 (1.52e9.48) 8.7 (3.80e13.60)
Genitourinary system 29 (4.6) 3.4 (0e10.04) 0 (0.00)
Others 23 (3.9) 4.3 (0e12.73) 13.0 (0.0e26.76)
CI ¼ confidence interval; CIN ¼ contrast-induced nephropathy.
CIN was defined as an increase of serum creatinine of 0.5 mg/dL 48 to 72 hours after contrast-enhanced CT imaging.
*p < 0.001 with versus without comparison by Chi-square analysis.
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in the ED.
Previous studies demonstrated that the development of CIN
is associated with a longer hospital stay, long-term dialysis, and
in-hospital mortality.2,5,7 It is essential that emergency physi-
cians identify any possible risk factors for deterioration of renal
function in ED patients undergoing CT scans. The results of our
multivariate analysis identified diabetes mellitus, precontrast
sCr >1.5 mg/dL, and acute hypotension, as risk factors for the
development of CIN. Pre-existing renal impairment had been
commonly identified as a predictor of CIN in patients receiving
CT scans, even conferring a 3.8-fold risk relative to patients with
normal renal function.16e18 Diabetes mellitus has also been
shown to be an important risk factor for CIN, after stratification
by baseline renal function.18,20 This finding is consistent with
previous studies of patients receiving coronary angiography.2,10
Although some factors including heart failure, hypertension,
anemia, and left ventricular eject fraction <40% were found in
other studies to be associated with an increased risk of CIN in
patients undergoing coronary angiography or intervention, they
were not found to be associated with an increased risk in this
study.3,6,7,11 A relatively small volume of intravenous contrast
medium, a procedural variable, may not increase the risk of
CIN.21,22
In a study by Mehran and colleagues, in which the authors
attempted to develop a contrast nephropathy risk score, eight
factors (hypotension, intra-arterial balloon pump, congestive
heart failure, age>75 years, anemia, diabetes mellitus, chronic
renal disease, and volume of contrast) were identified to be
predictive of CIN and increased 1-year mortality in patients
undergoing percutaneous coronary intervention.7 However,
these risk factors are too complex, and some variables cannot be
obtained in the ED setting. We re-evaluated these risk factors
and then developed a risk score to evaluate CIN incidence and
mortality for our ED patients. In our study, only three factors
(diabetes mellitus, precontrast sCr >1.5 mg/dL, and acute hy-
potension) were identified, and the integer scores were set based
on the adjusted ORs (Table 3). The analyses indicated that an
increasing score was associated with an exponential increased
risk of CIN ( p < 0.001) and mortality ( p ¼ 0.001). Further-
more, we categorized these patients into three risk grades; low,medium, and high risk (Fig. 3). Patients in the high risk group
deserved closer attention, due to their higher incidence of CIN
(28.9% vs. 8.6% overall) and higher mortality rate (37.8% vs.
13.1% overall). In addition, in-hospital mortality in patients
with CIN was higher than that in those without CIN (47.1% vs.
9.9%, respectively, p < 0.001). Although our results did not
indicate a statistically significant correlation of mortality with
increasing age in patients 65 years of age, there appears to be
a trend such that mortality increases as age increases (Fig. 2). In
addition, we demonstrated that the use of CIN risk scores in
elderly patients seen in the ED, who receive intravenous
contrast, can predict the incidence of CIN and mortality. These
results offer a clinical model for further studies regarding CIN
prevention in the ED.
In our analysis of the association between certain diseases
and the risk of CIN, we found that only patients with sepsis of
an unknown origin had a greater mortality than nonsepsis
patients ( p < 0.001). We also categorized all 594 patients into
infectious and noninfectious groups, but no statistical differ-
ence in mortality was noted (data not shown). A greater
number of patients are needed to clarify the relationship be-
tween different diseases and CIN incidence and mortality. The
differing severity in the same group and complicated diseases
involving two or more organ systems might contribute to this
result. Simply using a different organ-based diagnosis cannot
correlate with the development of CIN in our patients. How-
ever, it remains necessary for ED practitioners to implement
more effective and prompt medical management of sepsis to
improve outcomes in elderly patients.
There are several potential limitations to the present study.
This study was performed at a single ED of an urban academic
medical center, and results may be different in other settings.
The data was collected retrospectively, and the number of
cases involved in our study was not large enough to analyze
subgroups in different diagnosis categories. Some clinical
factors were not analyzed, such as medications that may affect
renal function. In the ED, it is not possible to more accurately
evaluate renal function (such as with a 24-h urine creatinine
test) before CT scanning. Finally, this scoring model was not
developed in a prospective case control design and was not
validated; further prospective data collection and studies to
276 M.-K. Huang et al. / Journal of the Chinese Medical Association 76 (2013) 271e276test the validity of the CIN risk scoring of elderly patients in
the ED are required.
In conclusion, the incidence of CIN in elderly patients who
received chest or abdominal CT, with intravenous contrast
medium in the ED, was 8.6%. Higher in-hospital mortality
was demonstrated in patients with CIN as compared to those
without CIN (47.1% vs. 9.9%, respectively). Diabetes melli-
tus, precontrast sCr >1.5 mg/dL, and acute hypotension were
found to be risk factors for CIN. A simple risk score model
was established to predict CIN and in-hospital mortality.
Further development and validation of this risk scoring model
and application to facilitate the prevention of CIN with pre-
ventive strategies for the elderly in the ED need further
investigation.
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